Three series of amidoxime derivatives including nitrous derivatives of a-chloro-a-isonitrosoacetone and hydrochlorides of O-aroyl-b-aminopropioamidoximes and 3-[b-(piperidin-1-yl)]ethyl-5-aryl-1,2,4-oxadiazoles were tested for conduction, infiltration, and terminal anesthesia. There are four interesting "hit" compounds, i.e., the hydrochloride of O-m-chlorophenyl-b-(benzimidazol-1-yl)propioamidoxime (VII), the hydrochlo-, which exhibit higher activity than the reference drugs (trimecaine, lidocaine, novocaine, kazcaine). As a whole, all tested compounds were active in conduction and infiltration anesthesia (at the level of the reference drugs) and did not show activity in terminal anesthesia. Compounds VII -X are of interest for further testing under condition and infiltration anesthesia conditions. Amidoximes are an attractive class of compounds with respect to their versatile reactivity at the imine and amine N atoms and the oxime O atom. As a result, various heterocyclic and linear derivatives containing pharmacophores that exhibit a broad spectrum of biological activity can be prepared [1]. These include antituberculosis, antimicrobial, antiviral, insecticidal, fungicidal, herbicidal, antidepressant, antihistamine, anti-inflammatory, local anesthetic, pyretic, etc. Several amidoximes are already used as drugs or are being tested in various phases of incorporation into medical 468 0091-150X/11/4508-0468 Note: p 1 , correlation coefficient relative to trimecaine; p 2 , relative to lidocaine; p 3 , relative to novocaine; p 4 , relative to kazcaine.